Both in Pharmaceuticals
Alnylam Pharmaceuticals vs ZOETIS
Over the past year ALNY returned −43.2% and ZTS returned −50.9%; their daily moves had a correlation of 0.16.
ALNY −43.2% ZTS −50.9%Growth of $1, one year, split-adjusted
| Metric | ALNY | ZTS |
|---|---|---|
| Price | $254.07 | $70.30 |
| Market cap | $34.00B | $29.05B |
| Today | −0.51% | −1.58% |
| 1 month | +7.2% | −9.1% |
| 6 months | −19.6% | −39.6% |
| Year to date | −36.1% | −44.1% |
| 1 year | −43.1% | −51.0% |
| Revenue growth (YoY) | +66.9% | −0.2% |
| Gross margin | 76.9% | 72.7% |
| Net margin | 12.7% | 28.0% |
| P/E (TTM) | 42.1× | 11.1× |
| Price / sales | 7.1× | 3.1× |
| Net cash | $2.30B | -$7.37B |
| Dividend yield | — | 3.02% |
| Volatility (60d) | 81.5% | 30.1% |
| Short % of float | 5.4% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).